State Stem Cell Agency ICOC Agenda 6/17-6/18 2009








California State Stem Cell Agency

MEETING NOTICE AND AGENDA

Regular meeting:
Independant Citizens’ Oversight Committee to the California Institute for Regenerative Medicine

Organized pursuant to Government Code section 11346.5(a)(17) and
the California Stem Cell Research and Cures Act

 

Date: Wednesday, June 17th, 2009

Time: 4:30-9:30 PM (Estimated)

Location:

To access the June 17th live event or archive, use this URL:
http://65.197.1.15/att/confcast
Enter Conference ID#101434  Then click Go.

Bel Aire Ballroom
Bay Tower
Sheraton San Diego Hotel & Marina
1580 Harbor Island Drive
San Diego, CA 92101

AND

Date: Thursday, June 18th, 2009

Time: 9:30 AM-5:00 PM (Estimated) 

Location:

To access the June 18th live event or archive, use this URL:
http://65.197.1.15/att/confcast
Enter Conference ID# 101436.  Then click Go.

Bel Aire Ballroom
Bay Tower
Sheraton San Diego Hotel & Marina
1580 Harbor Island Drive
San Diego, CA 92101

1.    Call to Order.

2.    Pledge of Allegiance.

3.    Roll Call.

[Members of the Public will be invited to provide testimony before or during consideration of each agenda item. Speakers are asked to limit their testimony to three (3) minutes.]

CONSENT ITEMS

4.    Approval of minutes from August 12-13, September 25, December 9-10, 2008; and January 29th-30th and March 12, 2009 ICOC meetings.

5.    Approval of updated CIRM Conflict of Interest Code.

REPORTS

6.     Chairman’s Report.

7.     President’s Report.

ACTION ITEMS

8.     Consideration of funding for approved CIRM Research Training Program II awards.

9.     Consideration of recommendations from Grants Working Group on Tier 2 Early Translational Research Awards applications.

CLOSED SESSION

10.    Discussion of confidential intellectual property or work product and prepublication, confidential scientific research or data relating to Early Translational Research Awards applications. (Health & Safety Code 125290.30(d) (3) (B) and (C)).

Public report of any action taken, if necessary, during closed session.

ACTION ITEMS

11.     Consideration of 2009-2010 CIRM Budget.

  1. Consideration of the 2009-10 CIRM Administrative Operating
    Budget
  2. 2009-10 Proposed Interagency and External Contract Budget Allocation
  3. Proposed 2009-10 Operating Budget
  4. CIRM Staffing Plan
  5. Travel - Office of the Chair

12.     Consideration of contract with Remcho, Johansen & Purcell, LLP.

13.     Consideration of consolidated Intellectual Property regulations. NO LONGER TO BE CONSIDERED AT THIS MEETING. TO BE CONSIDERED AT A FUTURE MEETING.

14.     Consideration of appointment of at-large members and leadership of Evaluation Subcommittee.

15.     Consideration of federal legislation, H.R. 1427/Waxman and H.R. 1548/Eshoo.

 

16.     Consideration of guidelines for open voting roll.

DISCUSSION ITEMS

17.     Public comment. The Committee will accept public testimony on any matter under its jurisdiction that is not on the agenda, but the Committee cannot act on any such matter at this meeting.

THE ORDER OF BUSINESS MAY BE CHANGED WITHOUT NOTICE.
Notice is hereby given that the order of consideration of matters on this agenda may be changed without prior notice.

 

**NOTICE**

The California Institute for Regenerative Medicine and its Independent Citizens Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact Melissa King at the California Institute for Regenerative Medicine at 415-396-9100 no later than the day prior to the meeting.

Questions or requests for additional information prior to the Independent Citizens Oversight Committee meeting may be referred to Melissa King at the California Institute for Regenerative Medicine at mking@cirm.ca.gov or 415-396-9100.

This meeting agenda is also available on the website for the California Institute for Regenerative Medicine at http://www.cirm.ca.gov .

Transcript URL: 
Transcript
Transcript URL 2: 
Transcript 2